These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5936672)

  • 1. Recovery with immunity after serial tapping of transplantable mouse ascites tumours.
    Apffel CA; Arnason BG; Twinam CW; Harris CA
    Br J Cancer; 1966 Mar; 20(1):122-6. PubMed ID: 5936672
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Immunochemical endgrouping" with Helix agglutinins of ascites tumor cells. Comparison with the blood cells of animals].
    Prokop O; Graffi A; Schnitzler S
    Acta Biol Med Ger; 1968; 20(3):Suppl:K9-K15. PubMed ID: 4302202
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival of host mice and induced resistance to transplantable ascites tumors.
    Kimura Y; Tanino T
    Jpn J Exp Med; 1966 Aug; 36(4):371-405. PubMed ID: 4291054
    [No Abstract]   [Full Text] [Related]  

  • 4. [Importance of specific and nonspecific immunity in anti-tumor defense].
    Biozzi G; Stiffel C; Mouton D; Bouthillier Y; Decreusefond C
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):685-94. PubMed ID: 5050875
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody-mediated immunity to transplantable tumors following reovirus oncolysis.
    Klein PA
    Pathol Microbiol (Basel); 1967; 30(2):222-45. PubMed ID: 4291735
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation.
    Tanino T
    Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
    Valguarnera G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):1013-6. PubMed ID: 4463978
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaphylactic tests for tumour antigen in transplantable animal tumours.
    Dale MM
    Br J Cancer; 1966 Jun; 20(2):326-34. PubMed ID: 4161442
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of Graffi leukemia virus and virus-induced antigens in leukemic and nonleukemic tissues of mice.
    Pasternak G; Pasternak L
    J Natl Cancer Inst; 1967 Feb; 38(2):157-68. PubMed ID: 5335577
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histocompatibility antigens of 2 transplantable reticulum cell tumors TRH 3 and TRBL 3 (induced in BALB/c/Cb/Se and C57BL/Cb/Se mice with ascites mammary carcinoma ATPC+). I. Transplantability tests].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1975; 35(1):29-41. PubMed ID: 1243772
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specific growth rate and macrophagal infiltration of experimental tumors].
    Kharatseius DA; Montsevichiute-Eringene EV
    Eksp Onkol; 1985; 7(5):45-7. PubMed ID: 4065019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive growth of transplanted tumors is accompanied by increasing serum concentrations of murine gamma fetal antigen.
    Higgins PJ; Marucs S; Hawrylko E
    Oncodev Biol Med; 1981; 2(1-2):77-87. PubMed ID: 6795603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of rubomycin C on the formation of hemagglutinins in animals with transplanted tumors].
    Shorin VA; Shapovalova SP
    Antibiotiki; 1969 Nov; 14(11):991-6. PubMed ID: 5395874
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression versus immunity in syngeneic and allogeneic tumours.
    Vlachov K; Nouza K
    Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune response against apparently host-compatible transplantable tumors.
    Manson LA; Goldstein L; Thorn R; Palmer J
    Transplant Proc; 1975 Jun; 7(2):161-4. PubMed ID: 1129841
    [No Abstract]   [Full Text] [Related]  

  • 18. Some biologic and biochemical properties of soluble tumor antigens.
    Law LW; Appella E; Henriksen O; Rogers M
    Ann N Y Acad Sci; 1976; 276():11-25. PubMed ID: 194514
    [No Abstract]   [Full Text] [Related]  

  • 19. Altered survival times of murine skin allografts from cancer-bearing donors.
    Kaliss N; Suter RB
    Transplantation; 1968 Oct; 6(7):844-8. PubMed ID: 4881646
    [No Abstract]   [Full Text] [Related]  

  • 20. Basic proteins and synthetic polynucleotides as modifiers of immunogenicity of syngeneic tumor cells.
    Braun W; Plescia OJ; Raskova J; Webb D
    Isr J Med Sci; 1971 Jan; 7(1):72-82. PubMed ID: 4100526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.